Drug property optimization: design, synthesis, and characterization of novel pharmaceutical salts and cocrystal-salt of lumefantrine (2025)
- Authors:
- USP affiliated authors: ANDO, RÔMULO AUGUSTO - IQ ; ARAUJO, GABRIEL LIMA BARROS DE - FCF ; OWOYEMI, BOLAJI CHARLES DAYO - FCF
- Unidades: IQ; FCF
- DOI: 10.1021/acs.molpharmaceut.4c01244
- Subjects: ESTRUTURA QUÍMICA; SAIS; ANTIMALÁRICOS; DIFRAÇÃO POR RAIOS X; SOLUBILIDADE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2025
- Source:
- Título: Molecular Pharmaceutics
- ISSN: 1543-8384
- Volume/Número/Paginação/Ano: v. 22, n. 2, p. 1042–1060, 2025
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
OWOYEMI, Bolaji Charles Dayo et al. Drug property optimization: design, synthesis, and characterization of novel pharmaceutical salts and cocrystal-salt of lumefantrine. Molecular Pharmaceutics, v. 22, n. 2, p. 1042–1060, 2025Tradução . . Disponível em: https://dx.doi.org/10.1021/acs.molpharmaceut.4c01244. Acesso em: 24 dez. 2025. -
APA
Owoyemi, B. C. D., Zeller, M., Silva, B. P. da, Akinyemi, A. O., Ando, R. A., Araujo, G. L. B. de, & Byrn, S. R. (2025). Drug property optimization: design, synthesis, and characterization of novel pharmaceutical salts and cocrystal-salt of lumefantrine. Molecular Pharmaceutics, 22( 2), 1042–1060. doi:10.1021/acs.molpharmaceut.4c01244 -
NLM
Owoyemi BCD, Zeller M, Silva BP da, Akinyemi AO, Ando RA, Araujo GLB de, Byrn SR. Drug property optimization: design, synthesis, and characterization of novel pharmaceutical salts and cocrystal-salt of lumefantrine [Internet]. Molecular Pharmaceutics. 2025 ; 22( 2): 1042–1060.[citado 2025 dez. 24 ] Available from: https://dx.doi.org/10.1021/acs.molpharmaceut.4c01244 -
Vancouver
Owoyemi BCD, Zeller M, Silva BP da, Akinyemi AO, Ando RA, Araujo GLB de, Byrn SR. Drug property optimization: design, synthesis, and characterization of novel pharmaceutical salts and cocrystal-salt of lumefantrine [Internet]. Molecular Pharmaceutics. 2025 ; 22( 2): 1042–1060.[citado 2025 dez. 24 ] Available from: https://dx.doi.org/10.1021/acs.molpharmaceut.4c01244 - Crystal engineering: synthesis and characterization of malate and malonate salts of lumefantrine and their Structure–property studies
- Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method
- Amorphous dispersions of flubendazole in hydroxypropyl methylcellulose: formulation stability assisted by pair distribution function analysis
- Unexpected single crystal growth induced by a wire and new crystalline structures of lapatinib
- Local structure of ion pair interaction in Lapatinib Amorphous Dispersions characterized by Synchrotron X-Ray diffraction and pair distribution function analysis
- Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin
- Pré-formulação
- Iniciação Científica: uma reflexão e estudo de caso sobre o aprendizado e o aprimoramento de capacidades pela aplicação de metodologias de solução de problemas
- Exploratory study on physicochemical properties of nitazoxanide nanocrystalline suspension obtained by evaporative solvent-antisolvent technique
- Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler]
Informações sobre o DOI: 10.1021/acs.molpharmaceut.4c01244 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3239737.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
